泰坦製藥 TTNP 深 滬
等待開盤 05-22 09:30:00 美东时间
4.61
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 4.61
- 總市值 613.22万
- 52周最高 5.76
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.03
- 委 比 0.00%
- 總股本 133.02万
- 歷史最高 36000.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.03
- 每 手 1
- 風險率 0.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
Aterian, Inc. announced the sale of its e-commerce brand portfolio, including Mueller Living, PurSteam, and others, to Trademark Global for $18 million, subject to adjustments. The deal requires shareholder approval and is expected to close in Q2 2026, with proceeds distributed to shareholders in Q3. Aterian also secured a $7 million strategic investment from David Lazar, who will become CEO following the transaction. Lazar has waived rights to a...
04-28 12:00
Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation
Titan Pharmaceuticals, Inc. completed its merger with Black Titan Corporation and TalenTec Sdn. Bhd. The combined company will trade as BTTC on Nasdaq. Titan became a wholly owned subsidiary of Black Titan on Oct. 1, 2025, with its shares converted into Black Titan's shares at a 1:1 ratio. Trading of Titan's stock ceased on Oct. 1, and Black Titan's shares began trading on Oct. 2. CEO Chay W. J. emphasized a new chapter of innovation and global e...
2025-10-03 21:26
Titan Pharmaceuticals Undergoes Leadership Restructuring
An update from Titan Pharmaceuticals ( ($TTNP) ) is now available. On October 1...
2025-10-02 04:51
Titan Pharmaceuticals Completes Merger with Black Titan; Shares to Begin Trading Under New Entity on Nasdaq
Titan Pharmaceuticals Inc. has completed its previously announced business combination with Black Titan Corporation, according to a company filing. The transaction, finalized on October 1, 2025, saw T...
2025-10-02 04:21
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Check-Cap (NASDAQ:CHEK) stock rose 25.5% to $2.66 during Monday's afte...
2025-09-16 05:06
Titan Pharmaceuticals Approves Merger with Black Titan
Titan Pharmaceuticals ( ($TTNP) ) just unveiled an update. On August 26, 2025, ...
2025-08-27 04:32
Titan Pharmaceuticals Announces Merger with Black Titan
New activity is brewing for Titan Pharmaceuticals ( ($TTNP) ). The company has ...
2025-07-23 05:33
Titan Pharmaceuticals Completes Securities Purchase Agreement
Titan Pharmaceuticals ( ($TTNP) ) just unveiled an update. On June 24, 2025, Ti...
2025-06-28 04:59
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
Titan Pharmaceuticals announced the completion of a private placement of 60,000 shares of its Series C Convertible Preferred Stock to Blue Harbour Asset Management for $600,000 at a conversion price of $3.40. The transaction includes a beneficial ownership blocker limiting Blue Harbour to a maximum of 19.99% of the Company's outstanding common stock. The shares were sold under Regulation S and are subject to a registration rights agreement. Addit...
2025-06-27 20:05
Titan Pharmaceuticals Announces Filing By Black Titan Corporation With SEC For Previously Announced Proposed Combination Of Titan And TalenTec
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission ("SEC") of a registration statement on Form F-4
2025-06-03 20:49
